132 related articles for article (PubMed ID: 1546411)
1. Prognostic significance of flow-DNA analysis and cell surface isoantigens in carcinoma of bilharzial bladder.
Shaaban AA; Javadpour N; Tribukait B; Ghoneim MA
Urology; 1992 Mar; 39(3):207-10. PubMed ID: 1546411
[TBL] [Abstract][Full Text] [Related]
2. ABH cell surface isoantigens in invasive bladder carcinoma associated with schistosomiasis.
El Adl MM; Yamase HT; Nieh PT; Mostofa AS; Hinz CF; Walzak MP
J Urol; 1984 Feb; 131(2):249-51. PubMed ID: 6366249
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis.
Nguyen PL; Swanson PE; Jaszcz W; Aeppli DM; Zhang G; Singleton TP; Ward S; Dykoski D; Harvey J; Niehans GA
Am J Clin Pathol; 1994 Feb; 101(2):166-76. PubMed ID: 7906919
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in bladder cancer. A pathologic, immunohistochemical, and DNA flow-cytometric study.
Lopez-Beltran A; Croghan GA; Croghan I; Matilla A; Gaeta JF
Am J Clin Pathol; 1994 Jul; 102(1):109-14. PubMed ID: 8037155
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of bromodeoxyuridine high labeled bladder cancer measured by flow cytometry: does flow cytometric determination predict the prognosis of patients with transitional cell carcinoma of the bladder.
Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
J Urol; 1993 Apr; 149(4):739-43. PubMed ID: 8455234
[TBL] [Abstract][Full Text] [Related]
6. ABH isoantigens in bladder carcinoma patients grouped according to DNA changes over time.
Borgström E; Gustafson H
Scand J Urol Nephrol; 1987; 21(2):125-30. PubMed ID: 3616504
[TBL] [Abstract][Full Text] [Related]
7. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
8. Cell surface antigen in bilharzial bladder tumours.
Halim A; Javadpour N; Kasraeian A; Young JD
Br J Urol; 1986 Oct; 58(5):523-5. PubMed ID: 3096417
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis.
Lee SE; Park MS
Eur Urol; 1996; 29(2):193-8. PubMed ID: 8647146
[TBL] [Abstract][Full Text] [Related]
10. ABH isoantigens, histology and DNA ploidy in 36 consecutive patients with transitional cell bladder cancer. Status of tumor and biopsies taken from visually normal urothelium.
Borgström E; Nyman C; Lönn M
Urol Res; 1987; 15(4):199-202. PubMed ID: 3672667
[TBL] [Abstract][Full Text] [Related]
11. Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma.
Malmström PU; Busch C; Norlen BJ; Andersson B
Scand J Urol Nephrol; 1988; 22(4):265-70. PubMed ID: 3238331
[TBL] [Abstract][Full Text] [Related]
12. Radical cystectomy for carcinoma of bilharzial bladder. Technique and results.
Ghoneim MA; El-Hamady SM; El-Bolkainy MN; Ashamallah AG; Mansour MA; Soliman ES
Urology; 1976 Dec; 8(6):547-52. PubMed ID: 997049
[TBL] [Abstract][Full Text] [Related]
13. Image cytometric DNA analysis in transitional cell carcinoma of the bladder.
Schapers RF; Ploem-Zaaijer JJ; Pauwels RP; Smeets AW; van den Brandt PA; Tanke HJ; Bosman FT
Cancer; 1993 Jul; 72(1):182-9. PubMed ID: 8508404
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in survival of bladder cancer.
Lopez-Beltran A; Croghan GA; Croghan I; Huben RP; Mettlin C; Gaeta JF
Cancer; 1992 Aug; 70(4):799-807. PubMed ID: 1643611
[TBL] [Abstract][Full Text] [Related]
15. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
16. Image and flow cytometric analyses of DNA content in human solid tumors. A comparative study.
Faranda A; Costa A; Canova S; Abolafio G; Silvestrini R
Anal Quant Cytol Histol; 1997 Aug; 19(4):338-44. PubMed ID: 9267567
[TBL] [Abstract][Full Text] [Related]
17. Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases.
Shaaban AA; Elbaz MA; Tribukait B
Urology; 1998 Mar; 51(3):469-76. PubMed ID: 9510355
[TBL] [Abstract][Full Text] [Related]
18. Combination of blood group ABH antigen status and DNA ploidy as independent prognostic factor in transitional cell carcinoma of the urinary bladder.
Malmström PU; Norlén BJ; Andersson B; Busch C
Br J Urol; 1989 Jul; 64(1):49-55. PubMed ID: 2765768
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
Shimizu K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
[TBL] [Abstract][Full Text] [Related]
20. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
